Found 6 resultsAuthor [ Title] Type Year
Filters: Author is Brady, RC [Clear All Filters]
Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults. Vaccine, 29, 5666-5674. presented at the 08/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21699951. (2011).
Dose-Related Safety and Immunogenicity of A Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults. J Infec Dis, 193, 1223-1228. presented at the 05/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16586358. (2006).
Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons. J Infect Dis, 206, 811-820. presented at the 09/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22782949. (2012).
Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations. Vaccine, 33, 163-173. presented at the 01/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25444805. (2015).
Safety and Immunogenicity of a Subvirion Inactivated Influenza a/H5N1 Vaccine With or Without Aluminum Hydroxide Among Healthy Elderly Adults. Vaccine, 27, 5091-5095. presented at the 08/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=19577636. (2009).
Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine. J Amer Med Assn, 292, 1205-1212. presented at the 2004.. (2004).